Home1SXP • ETR
add
SCHOTT Pharma AG & Co KgaA
Nakaraang pagsara
€20.00
Sakop ng araw
€19.60 - €20.20
Sakop ng taon
€18.50 - €32.74
Market cap
2.96B EUR
Average na Volume
56.65K
P/E ratio
20.43
Dividend yield
0.80%
Primary exchange
ETR
Mga balita tungkol sa merkado
Financial Post
1 araw ang nakalipas
With the TSX in 'rarefied territory,' is it time to get defensive?
1.15%
Mga Financial
Income Statement
Kita
Net na kita
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 256.46M | 1.13% |
Gastos sa pagpapatakbo | 35.98M | 10.22% |
Net na kita | 45.56M | -1.51% |
Net profit margin | 17.77 | -2.58% |
Kita sa bawat share | 0.30 | -3.23% |
EBITDA | 79.85M | 12.55% |
Aktuwal na % ng binabayarang buwis | 23.96% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 28.29M | 27.69% |
Kabuuang asset | 1.53B | 9.23% |
Kabuuang sagutin | 663.12M | 5.30% |
Kabuuang equity | 865.03M | — |
Natitirang share | 151.88M | — |
Presyo para makapag-book | 3.52 | — |
Return on assets | 9.97% | — |
Return on capital | 13.15% | — |
Cash Flow
Net change in cash
| (EUR) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 45.56M | -1.51% |
Cash mula sa mga operasyon | 55.18M | -4.73% |
Cash mula sa pag-invest | -37.89M | -56.48% |
Cash mula sa financing | -14.41M | 52.04% |
Net change in cash | 2.20M | -29.99% |
Malayang cash flow | -28.83M | -170.61% |
Tungkol
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
Itinatag
Ago 1, 2022
Website
Mga Empleyado
4,775
